ASKA Pharmaceutical Holdings Co.,Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
8.37 | 110.39 | -92.42% | 8.2 | +2.07% |
| P/S |
|
1 | 74.99 | -98.66% |
|
|
| P/BV |
|
1.02 | 70.27 | -98.55% |
|
|
| P/FCF |
|
1210.3 | 79.2 | 1428.18% |
|
|
| Ev/Ebitda |
|
4.69 | 16.85 | -72.2% |
|
|
| Ev/S |
|
0.937 | 80.73 | -98.84% |
|
|
| Ev/FCF |
|
1784.39 | 24.73 | 7116.32% |
|
|
| E/P |
|
0.1889 | -0.1555 | -221.5% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
20 | -144.44 | -113.85% | 15.94 | +25.43% |
| ROE |
|
12.96 | -9.24 | -240.19% |
|
|
| ROA |
|
8.48 | -9.69 | -187.54% |
|
|
| ROIC |
|
7.49 | 9.09 | -17.62% |
|
|
| ROS |
|
12.01 | -211.07 | -105.69% |
|
|
| ROCE |
|
15.99 | 6.03 | 165.13% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.7548 | -1.04 | -172.41% | 1.44 | -47.75% |
| Nеt Debt/Ebitda |
|
-0.3384 | 12.51 | -102.71% |
|
|
| Debt/Ratio |
|
0.1045 | 0.1401 | -25.4% |
|
|
| Debt/Equity |
|
0.8786 | 40.14 | -97.81% |
|
|
| Debt/Net Income |
|
1.26 | -1.96 | -164.15% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6.43/10
|
2.57 | 2.65 | -3.16% | 1.95 | +32.05% |
| Number of years of dividend growth |
|
3 | 1.28 | 133.68% | ||
| DSI |
|
1 | 0.7376 | 35.58% |
|
|
| Average dividend growth |
|
49.72 | -18.51 | -368.71% |
|
|
| Average percentage for 5 years |
|
1.95 | 1.9 | 2.3% |
|
|
| Average percentage for payments |
|
21.92 | 32.83 | -33.23% |
|
|
| Difference from average difference in sector |
|
-0.084 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
19.61 | 87.09 | -77.48% | ||
| Growth impulse Ebitda in 5 years |
|
138.46 | 69.14 | 100.26% | ||
| Growth impulse Net Income in 5 years |
|
1062.56 | 31.67 | 3255.1% | ||
| Growth impulse FCF in 5 years |
|
-101.29 | -20.71 | 389.09% | ||
| Growth impulse EPS in 5 years |
|
1061.66 | -36.16 | -3036.01% |
IP Score
6.55/10
